Who invested in Diamond Therapeutics?
2 investors are on record as having backed Diamond Therapeutics — Developing sub-perceptual, non-hallucinogenic treatments based on psychedelic compounds, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
diamondthera.comDiamond Therapeutics investors
Grey House Partners Gp Inc.Invests in early-stage mental health and wellbeing technologies, including psychedelic…their site
Palo SantoInvests in next-generation neuroscience companies developing breakthrough therapeutics…their site
No round dates are on record for Diamond Therapeutics. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Diamond Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.